welbournes

Drug alert number: EL (24)A/62 Date issued: 9 December 2024 Wockhardt UK Limited is recalling this batch as a precautionary measure following the identification of a low number of units which may have a defect in the ‘top case’ resulting in a dose not being able to be dispensed. WockAIR 160 microgram/4.5 microgram, inhalation powder, [...]

The post MHRA Class 2 Medicines Recall: WockAIR 160 microgram/4.5 microgram, inhalation powder (Wockhardt UK Limited) appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (03/12/2024) announced the following final list of price concessions for November 2024: Please note these prices only apply to prescriptions submitted as dispensed in November 2024. Community Pharmacy [...]

The post November 2024 Price Concessions Final Update appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Coal tar extract (Neutrogena® T/Gel® Therapeutic) 2% shampoo MSN/2024/111 Tier 2 – medium impact Date of issue: 3rd December 2024 Coal tar extract (Neutrogena® T/Gel® Therapeutic) 2% shampoo (all pack sizes) is being discontinued from February 2025 Alternative coal tar extract [...]

The post Medicine Supply Notification: Coal tar extract (Neutrogena® T/Gel® Therapeutic) 2% shampoo appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (29/11/2024) announced the following list of price concessions for November 2024: This is not the final update for November. We are still working with the DHSC to agree [...]

The post November 2024 Price Concessions 4th Update appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Information: Liothyronine Sodium 5 & 20 micrograms Tablets (Strides Pharma UK Ltd) Drug alert number: EL (24)A/58 Date issued: 28 November 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Liothyronine Sodium 5 & 20 micrograms Tablets (Strides Pharma UK [...]

The post MHRA Class 4 Medicines Defect Information: Liothyronine Sodium 5 & 20 micrograms Tablets (Strides Pharma UK Ltd) appeared first on Community Pharmacy England.